1Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von willebrand factor. Blood, 2001,98:2730-2735. 被引量:1
2Furlan M, Robles R, Solenthaler M,et al. Deficient activity of van willebrand factor-cleaving protease in chronic thrombotic thrombocytopenic purpura and haemolytic uraemik syndrome:the role of van willebrand factor-cleaving protease. Best Pract Clin Haem 被引量:1
3Nabhan C, Kwaan HC. Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura. Hematol Oncol Clin North Am, 2003, 17:177-199. 被引量:2
4Proia A, Paesano R, Torcia F, et al. Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literature. Ann Hematol, 2002, 81:210-214. 被引量:2
5Bynes JJ, Moake JL.Thrombotic thrombocytopenic purpura and haemolytic hraemik syndrome evolving concepts of pathogenesis and therapy. Clin Haematol, 1986,15:413-442. 被引量:1
6McMinn JR, George JN.Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apheresis, 2001,16:202-209. 被引量:1
7Coai EM, Puzis L, Tsai HM, et al. Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plaa exchange and infusion. Eur J Haematol,2002,68:239-242. 被引量:1
2Sadler JE, Moake JL, Miyata T,et al. Recent adances in thrombotic thrombocytopenic purpura[J]. American Society of Hematology,2004,42(6) : 407-422. 被引量:1
3McMinn JR, George JN. Evaluation of women with clinically suspected Thrombotic Thrombocytopenic Purpnra-Hemolytic Uremic Syndrome During Pregnancy[J]. Jourmal of Apheresis,2001, 16 (4) : 202-209. 被引量:1
4Scully M, Starke R, Lee R, et al. Successful management of pregnancy in women with a history of thrombotic thrombocytopenic purpura [ J ]. Blood Coagul Fibrinolysis, 2006, 17 ( 6 ) :459-463. 被引量:1
5George JN. The association of pregnancy with thrombotic Thrombocytopenic purpura-hemolytic uremic syndrome [ J ]. Curr Opin Hematol,2003, 10(5) :339-344. 被引量:1
6Ruggenenti P, Remuzzi G. Pathophysiology and management of thrombotic microangiopathies [J]. J Nephrol, 1998, 11 ( 6 ) : 300- 310. 被引量:1
7Tsai HM. Advance in the pathogenosis, and treatment of thrombotic thrombocytopenic purpura[ J]. J Am. Soc Nephrol,2003, 14 : 1072-1081. 被引量:1
9Hulstein JJ, Rison CN, Kappers-Klunne MC, et al. Activity loss of von Willebrand fector cleaving protein( ADAMTS-13 ) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura. [ J ]. Ned Tijdschr Geneeskd, 2004, 148 (40) : 1972-1976. 被引量:1